Detailansicht

Molecular Vaccines

From Prophylaxis to Therapy, 2 Bde
ISBN/EAN: 9783319011424
Umbreit-Nr.: 4977797

Sprache: Englisch
Umfang: 750 S., 600 s/w Illustr., 200 farbige Illustr., 75
Format in cm:
Einband: gebundenes Buch

Erschienen am 01.01.2020
Auflage: 1/2014
€ 160,49
(inklusive MwSt.)
Lieferbar innerhalb 1 - 2 Wochen
  • Zusatztext
    • The set of two volumes gives an detailed insight to all aspects of molecular vaccine development and application. Volume one provides a comprehensive overview to all aspects of global molecular vaccine research. It introduces concepts of vaccine immunology and molecular vaccine development for viral, bacterial, parasitic and fungal infections. Furthermore, the complex topic of cancer vaccines is discussed in detail. Volume two discusses all aspects of non-infectious and non-cancer- so called NINC - vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. Molecular Vaccines from Prophylaxis to Therapy is of interest for researchers and clinicians engaged in molecular vaccine development and application.
  • Kurztext
    • Provides detailed insight to the basic vaccine immunologyExplains how to use molecular vaccines in infectious diseases and cancerIllustrates the complete process of vaccine development from bench to preclinical and clinical studies and launch to the marketEnriches understanding of the use of nanotechnology in vaccine development